System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Pierre Bohn is an expert in Nuclear medicine at Centre Henri Becquerel (France). Pierre Bohn has authored 82 publications, the most recent in 2026. SLR score: 200 (community average: 125). How the SLR is computed.

LeadR Profile

Pierre Bohn Centre Henri Becquerel France
200 ScienceLeadR Reputation 200

Unlock

Register Login
Network Map

Nuclear medicine

Subspecialties: Pharmacy - Oncology - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026
Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 82

Citations

Citations: 971 1st author: 6 Last author: 16 Unique author: 1

Main journals

HAL (Le Centre pour la Communication Scientifique Directe) 18
MED NUCL 11
Org Biomol Chem 4
Cancers (Basel) 3
Radiother Oncol 3

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
GMP-compliant automated synthesis and quality control of [ 177Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer.
PMID 42154134 — quality control, neoplasms, prostate, prostatic neoplasms, castration, therapeutics		EJNMMI Radiopharm Chem20260
[Implementation of ⁶⁸Ga-FAPI-46 labelling as part of the PRECISION clinical trial.].
PMID 41698532 — quality control, breast neoplasms, neoplasms, pharmacology, breast		Ann Pharm Fr20260
Proposition of a user navigation program for an oncology clinic: Customizing patients’ journey through experience-based design
OpenAlex W4399713693		Proceedings of DRS20240
Influence de la température sur le marquage du Locametz®
OpenAlex W4392350665 — temperature		MED NUCL20240
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.
PMID 36980806 — head and neck neoplasms, oropharynx, radiotherapy, positron emission tomography computed tomography		Cancers (Basel)20234

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS